Although acute toxicity testing for the lowest tonnage is required via the oral route, for nanoforms, inhalation is considered as more appropriate route of exposure and should be required instead, unless the exposure to humans is unlikely.
Recital 18, Regulation (EU) 2018/1881
In forcesince 3 Dec 2018